FREM2 and central nervous system cancer: Much better results were obtained for the activation of FREM2 pathway, as PALs returned relatively higher AUC values and allowed all major types of gliomas to be distinguished from each other, with the only exception being low- and high-grade “astrocytomas, IDH-mutant”.